Transplantation, AutologousPeripheral Blood Stem Cell TransplantationHematopoietic Stem Cell TransplantationHematopoietic Stem Cell MobilizationTransplantation, HomologousBone Marrow TransplantationTransplantation ConditioningLeukapheresisGranulocyte Colony-Stimulating FactorMultiple MyelomaBlood Component RemovalRecurrenceHodgkin DiseaseTreatment OutcomeAntigens, CD34Hematopoietic Stem CellsStem CellsHematologic NeoplasmsGraft SurvivalMelphalanGraft vs Host DiseaseRetrospective StudiesCombined Modality TherapyCyclophosphamideSurvival AnalysisBlood CellsTissue DonorsAntineoplastic Combined Chemotherapy ProtocolsLeukocytes, MononuclearStem Cell TransplantationBusulfanBlood Cell CountLymphoma, Non-HodgkinImmunosuppressive AgentsCord Blood Stem Cell TransplantationEtoposideThiotepaKidney TransplantationMyeloablative AgonistsAntineoplastic Agents, AlkylatingTime FactorsT-LymphocytesHematopoiesisBlood Transfusion, AutologousRemission InductionHistocompatibilityWhole-Body IrradiationFlow CytometryHistocompatibility TestingBone Marrow PurgingTransplantation ChimeraLymphocytesLeukocyte CountImmunophenotypingDisease-Free SurvivalIfosfamidePlatelet CountBlood DonorsCell SeparationCells, CulturedBone MarrowSurvival RateLeukemiaCytarabineSalvage TherapyInfectionTransplantsAntigens, CDRecombinant ProteinsTransplantation, IsogeneicImmunomagnetic SeparationCytomegalovirus InfectionsVincristineCyclosporineVidarabineGraft RejectionPOEMS SyndromeLymphomaBone Marrow CellsFollow-Up StudiesNeoplasmsLymphocyte ActivationLeukemia, Myeloid, AcuteColony-Forming Units AssayImmunosuppressionAnemia, AplasticBone Marrow DiseasesPlatelet TransfusionCarmustineFeasibility StudiesProspective StudiesPeripheral NervesLymphocyte DepletionDoxorubicinPolymerase Chain ReactionHLA AntigensAcute DiseaseAmyloidosisAntibodies, MonoclonalMonocytes